Quantcast
Last updated on April 19, 2014 at 13:20 EDT

United BioSource Corp Scientists to Present at 17th Annual ISPOR Meeting in Washington, DC June 2-6, 2012

June 1, 2012

CHEVY CHASE, Md., June 1, 2012 /PRNewswire/ — Scientists from United BioSource Corporation (UBC), a wholly-owned subsidiary of Express Scripts Holding Company (NASDAQ: ESRX), will be presenting data at the 17th Annual International Society for Pharmacoeconomics and Outcomes Research (ISPOR) meeting June 2-6 in Washington, D.C.

UBC scientists have long played a central role in collaborating with ISPOR to translate the latest research in health economics and patient outcomes into useful information for healthcare decision makers.

SCHEDULE OF UBC PRESENTATIONS:

Bayesian Analysis – Overview and Applications
Sat., June 2, 8:00 a.m. – 5:00 p.m.
Faculty: David J. Vanness, PhD, Asst. Prof., Univ. of Wisconsin, School of Medicine and Public Health and Visiting Scientist, Health Economics and Science Policy, United BioSource Corp.; Christopher S. Hollenbeak, PhD, Assoc. Prof., Surgery and Public Health Sciences, Penn State College of Medicine

Discrete Event Simulation for Economic Analyses – Concepts
Sun., June 3, 8:00 a.m. – 12:00 p.m.
Faculty:
J. Jaime Caro, MDCM, FRCPC, FACP, Adjunct Prof. of Medicine, Adjunct Prof. of Epidemiology and Biostatistics, McGill Univ. and SVP Research, United BioSource Corp.; Jorgen Moller, MSc Mech Eng, VP, Modeling, United BioSource Corp.; Denis Getsios, Senior Dir., Senior Research Scientist, United BioSource Corp.

Bayesian Analysis – Advanced
Sun., June 3, 8:00 a.m. – 12:00 p.m.
Faculty:
Keith R. Abrams, PhD, Prof. of Medical Statistics, Dept. of Health Sciences, Univ. of Leicester; David J. Vanness, PhD, Asst. Prof., University of Wisconsin School of Medicine and Public Health and Visiting Scientist, Health Economics and Science Policy, United BioSource Corp.; Christopher S. Hollenbeak, PhD, Assoc. Prof. Surgery and Public Health Sciences, Penn State College of Medicine

Content Validity of PRO, ClinRO and ObsRO Assessments
Sun., June 3, 1:00 p.m. – 5:00 p.m.
Faculty:
Donald L. Patrick, PhD, MSPH, Prof. Univ. of Washington, Seattle Quality of Life; Mona L. Martin, RN, MPA, Exec. Dir. Health Research Associates; Chad Gwaltney, PhD, Sr. Scientist PRO Consulting and Asst. Prof. (Research), Brown Univ.; Nancy Kline Leidy, PhD, SVP Scientific Affairs, United BioSource Corp.

Discrete Event Simulation for Economic Analyses – Applications
Sun., June 3, 1:00 p.m. – 5:00 p.m.
Faculty:
J. Jaime Caro, MDCM, FRCPC, FACP, Adjunct Prof. of Medicine, Adjunct Prof. of Epidemiology and Biostatistics, McGill Univ. and SVP Research, United BioSource Corp.; Jorgen Moller, MSc Mech Eng, VP, Modeling, United BioSource Corp.; Denis Getsios, Senior Dir., Senior Research Scientist, United BioSource Corp.

Eliciting Patient-Centered Outcomes: Determining the Relative Strengths, Opportunities and Challenges of 5 Common Research Designs
SESSION I Mon., June 4, 4:45 p.m. – 5:45 p.m.
Discussion Leaders:
Bryan R. Luce, PhD, MBA, SVP Science Policy, United BioSource Corp.; Lori Frank, PhD, Research Scientist, Patient Centered Outcomes Research Institute; Karin S. Coyne, PhD, MPH, Senior Research Leader, Outcomes Research, United BioSource Corp.; Kathleen W. Wyrwich, PhD, Senior Research Leader, United BioSource Corp.

Comparative Effectiveness Research: Methods and Applications
SESSION III Wed., June 6, 8:30 a.m. – 9:30 a.m.
Discussion Leaders:
Donald L. Patrick, PhD, MSPH, Dir., Seattle Quality of Life Group, Univ. of Washington; Bryan R. Luce, PhD, MBA, SVP Science Policy, United BioSource Corp.; C. Daniel Mullins, PhD, Professor, Pharmaceutical Health Services Research Dept., Univ. of Maryland School of Pharmacy

Early Economic Evaluation of the Effectiveness of Pharmaceutical Development Candidates in Subpopulations: A Role for Clinical Trial Modeling and Simulation
SESSION IV Wed., June 6, 1:45 p.m. – 2:45 p.m.
Discussion Leaders:
Ananth Kadambi, PhD, Dir., Modeling and Simulation Development and Research Scientist, Health Economics, United BioSource Corp.; Robert Leipold, PhD, Research Scientist, Health Economics, United BioSource Corp.; Thomas Paterson, MS, Chief Technology Officer, Entelos; Christy J. Chuang-Stein, PhD, VP, Statistical Research and Consulting Center, Pfizer

EDUCATIONAL SYMPOSIUM
Pharmacoeconomic Modeling: The Road to Primetime
Tues., June 5, 11:15 a.m. – 12:15 p.m.
Moderator:
David M. Eddy, MD, PhD, Founder & CMO, Archimedes
Speakers: J. Jaime Caro, MDCM, FRCPC, FACP, Adjunct Prof. of Medicine, Adjunct Prof. of Epidemiology and Biostatistics, McGill Univ. and SVP Research, United BioSource Corp.; Sara Eggers, PhD, Economist, Office of Planning and Informatics, Center for Drug Evaluation and Research, FDA; Nevine Zariffa, MMath, Global Head Statistics and Programming, AstraZeneca; Janet Brock, Director, Div. of Operations & Information Management, Centers for Medicare & Medicaid Services

PODIUM PRESENTATION

Medication Adherence and Persistence of Prasugrel Initiators Post ACS-PCI
SESSION II
Mon., June 4, 3:15 p.m. – 3:30 p.m.
Simeone JC, Nordstrom B, Zhao Z, Molife C, McCollam PL, Ye X, Effron MB

For a full list of other upcoming UBC presentations, please go to: http://www.unitedbiosource.com/news/presentations.aspx

Founded in 1995, ISPOR is a non-profit 501(c)(3) with over 6200 members who are academicians, scientists and government officials from almost 100 countries. ISPOR facilitates and encourages communications among the research community, health care professionals, regulatory, and educational groups and acts as a resource in forming public policy relevant to the pharmacoeconomics/health economics, and issues of public concern. To view the full program, please go to: http://www.ispor.org/Events/Main.aspx?eventId=38

About United BioSource Corporation

United BioSource Corporation (UBC), a wholly owned subsidiary of Express Scripts Holding Company, is a global scientific and medical affairs organization that partners with life science companies to make medicine and medical products smarter for all stakeholders in the health care landscape. UBC helps deliver authoritative, real-world evidence to characterize product effectiveness, address safety risk, and demonstrate value. UBC brings together recognized scientific and industry experts, research operations professionals, and new technologies to provide innovative solutions across the product lifecycle. The company is headquartered in Chevy Chase, MD with offices in North and South America, Europe and Asia. For more information about UBC, visit www.unitedbiosource.com.

Media Contact:
Annette Larkin
Phone: 703-772-6427
e-mail: Annette.larkin@unitedbiosource.com

SOURCE United BioSource Corporation


Source: PR Newswire